![](https://media.asiaone.com/sites/default/files/styles/a1_600x316/public/original_images/Jun2024/pr-newswire_500_4_2007.jpg?h=7de12b8a&itok=dcgXMVRL)
Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight ...
SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of …